NO914946L - Syntetisk poly-ig-reseptor, reseptor-antistoff-komplekser, fremstilling og anvendelse derav - Google Patents

Syntetisk poly-ig-reseptor, reseptor-antistoff-komplekser, fremstilling og anvendelse derav

Info

Publication number
NO914946L
NO914946L NO91914946A NO914946A NO914946L NO 914946 L NO914946 L NO 914946L NO 91914946 A NO91914946 A NO 91914946A NO 914946 A NO914946 A NO 914946A NO 914946 L NO914946 L NO 914946L
Authority
NO
Norway
Prior art keywords
receptor
poly
monoclonal
methods
preparation
Prior art date
Application number
NO91914946A
Other languages
English (en)
Norwegian (no)
Other versions
NO914946D0 (no
Inventor
Jean-Pierre Kraehenbuhl
Richard A Weltzin
Marian R Neutra
Original Assignee
Harvard College
Suisse Rech Experiment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Suisse Rech Experiment filed Critical Harvard College
Publication of NO914946D0 publication Critical patent/NO914946D0/no
Publication of NO914946L publication Critical patent/NO914946L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO91914946A 1990-04-16 1991-12-13 Syntetisk poly-ig-reseptor, reseptor-antistoff-komplekser, fremstilling og anvendelse derav NO914946L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51016190A 1990-04-16 1990-04-16
PCT/US1991/002604 WO1991016061A1 (en) 1990-04-16 1991-04-16 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF

Publications (2)

Publication Number Publication Date
NO914946D0 NO914946D0 (no) 1991-12-13
NO914946L true NO914946L (no) 1992-02-12

Family

ID=24029610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914946A NO914946L (no) 1990-04-16 1991-12-13 Syntetisk poly-ig-reseptor, reseptor-antistoff-komplekser, fremstilling og anvendelse derav

Country Status (21)

Country Link
EP (1) EP0480014B1 (es)
JP (1) JPH05501118A (es)
KR (1) KR920702625A (es)
CN (1) CN1057785A (es)
AT (1) ATE145137T1 (es)
AU (2) AU7792691A (es)
BG (1) BG95634A (es)
BR (1) BR9105717A (es)
CA (1) CA2059289A1 (es)
DE (1) DE69123121T2 (es)
DK (1) DK0480014T3 (es)
ES (1) ES2097207T3 (es)
FI (1) FI915881A0 (es)
GR (1) GR3022512T3 (es)
HU (1) HUT63059A (es)
NO (1) NO914946L (es)
OA (1) OA09647A (es)
RO (1) RO109703B1 (es)
RU (1) RU2124050C1 (es)
WO (1) WO1991016061A1 (es)
ZA (1) ZA912837B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0675734A4 (en) * 1992-12-21 1997-05-07 Tanox Biosystems Inc ALLERGY SPECIFIC, MONOCLONAL IgA ANTIBODIES AND SIMILAR PRODUCTS FOR ALLERGY TREATMENT.
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
US6808709B1 (en) 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
WO1996021012A1 (en) 1994-12-30 1996-07-11 Planet Biotechnology, Inc. Methods for producing immunoglobulins containing protection proteins in plants and their use
EP0839915A1 (en) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Secretory immunoglobulin A as a mucosal vaccine delivery system
ATE442386T1 (de) 2000-04-28 2009-09-15 Planet Biotechnology Inc Immunoadhesin zur impfung gegen rhinovirus
AU2001272908A1 (en) 2000-05-10 2001-11-20 David A. Sirbasku Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
RU2186390C1 (ru) * 2001-01-26 2002-07-27 Научно-исследовательский институт эпидемиологии и микробиологии им. Н.Ф. Гамалеи РАМН Способ выделения пневмоцист
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
CN104903727B (zh) * 2012-11-08 2019-10-22 马克法兰伯尼特医学研究与公共健康协会有限公司 诊断、预后、治疗和筛选方案
RU2605321C1 (ru) * 2015-07-16 2016-12-20 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Фракция днк-гидролизующих секреторных иммуноглобулинов класса а, обладающая избирательной апоптотической активностью по отношению к раковым клеткам человека

Also Published As

Publication number Publication date
JPH05501118A (ja) 1993-03-04
AU687443B2 (en) 1998-02-26
DE69123121T2 (de) 1997-04-03
BG95634A (bg) 1993-12-24
DE69123121D1 (de) 1996-12-19
AU7792691A (en) 1991-11-11
EP0480014A1 (en) 1992-04-15
HUT63059A (en) 1993-07-28
BR9105717A (pt) 1992-07-21
DK0480014T3 (da) 1997-02-17
ES2097207T3 (es) 1997-04-01
GR3022512T3 (en) 1997-05-31
NO914946D0 (no) 1991-12-13
ZA912837B (en) 1992-03-25
OA09647A (en) 1993-04-30
FI915881A7 (fi) 1991-12-13
AU7771594A (en) 1995-04-06
CA2059289A1 (en) 1991-10-17
WO1991016061A1 (en) 1991-10-31
FI915881A0 (fi) 1991-12-13
RO109703B1 (ro) 1995-05-30
EP0480014A4 (en) 1992-10-14
CN1057785A (zh) 1992-01-15
KR920702625A (ko) 1992-10-06
HU9200136D0 (en) 1992-04-28
RU2124050C1 (ru) 1998-12-27
EP0480014B1 (en) 1996-11-13
ATE145137T1 (de) 1996-11-15

Similar Documents

Publication Publication Date Title
DE69023900T2 (de) Gentechnologisch veränderte immunglobuline.
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
PT91294A (pt) Processo para a preparacao de construtos de antigenes a partir de antigenes da classe i de "complexo de histocompatibilidade principal" com moleculas de suporte especificas e de composicoes farmaceuticas que os comtem
KR930700662A (ko) 인간화된 단클론성 항체 및 혼성 단클론성 항체
JP2006526414A5 (es)
CA2290485A1 (en) Method for the production of non-immunogenic proteins
NO963120L (no) Monoklonale antistoffer som binder til tumorrejeksjons-antigenforlöperen MAGE-3, rekombinant MAGE-1, og MAGE-1 avledete immunogene peptider
ES2088873T3 (es) Celulas dotadas con especialidad de anticuerpos.
RU2003131869A (ru) Измененные полипептиды с увеличенным временем полужизни
WO1991004273A3 (en) Novel peptides associated with the cd4 binding region of gp120 and their methods of use
DK0480014T3 (da) Syntetisk poly-lg-receptor, receptor-antistof-komplekser, fremstilling og anvendelse deraf
WO2025038726A3 (en) Interleukin 21 variants
Schlebusch et al. A monoclonal antiidiotypic antibody ACA 125 mimicking the tumor-associated antigen CA 125 for immunotherapy of ovarian cancer
Flajnik et al. Reagents specific for MHC class I antigens of Xenopus
AU7196098A (en) Induction of protection against viral infection
KR960703618A (ko) 비활성화된 호흡기 신시튬 바이러스 백신
AU4872790A (en) Rat monoclonal antibodies directed against human antigens and processes for preparation thereof
Lachmann et al. The heterogenization of tumour cells with tuberculin. I. The coupling of tuberculin to cell surfaces using con-A as ligand
US20030099934A1 (en) Chemically modified hiv envelope glycoprotein
WO2025255558A3 (en) Anti-thymic stromal lymphopoietin (tslp) antigen-binding proteins and uses thereof
KR950701821A (ko) 피임 백신(contraceptive vaccine)
WO2000018429A3 (en) Vaccine based on attenuated $i(haemophilus somnus)
LEVITT TWO INTEGRATED PARTIAL REPEATS OF SV40 TOGETHER CODE FOR A SUPER-T ANTIGEN (TUMOR ANTIGENS, DUPLICATIONS, AMPLIFICATION)
Ljunggren Immunization against polyoma virus-induced tumors with synthetic peptides.
Ismail et al. Membrane D2 T antigen: characterization and comparison with its nuclear counterpart